NAD(P)H: quinone oxidoreductase 1 inducer activity of novel 4-aminoquinazoline derivatives

References

• Kiruthiga B, Ilango K, Valentina P, Umarani N. Ritesh. Synthesis of some new 2-substituted quinazolin-4-one derivatives and their biological activities. Int J Pharm Tech Res 2009;1:1503–6.
   Google Scholar
• Rani P, Archana S, Srivastava VK, Kumar A. Synthesis and anti-inflammatory activity of some new 2,3-disubstituted-6-monosubstituted-quinazolin-4(3H)-ones. Ind J Heterocycl Chem 2002;41B:2642–6.
   Google Scholar
• Pandya T, Chaturvedi SC. QSAR study of a series of 2, 3, 6-substituted quinazolinones as AT1 selective angiotensin II receptor antagonists. Ind J Chem 2004;43B:2440–5.
   Google Scholar
• Chandra T, Garg N, Kumar A. Synthesis of sulpha drug quinazolin-4-one derivatives and their evaluation for anti-inflammatory activity. World J Chem 2009;4:210–18.
   Google Scholar
• Meyyanathan SN, Murali KE, Chandrashekhar HR, et al. Synthesis of some amino acids incorporated4(3H)-quinazolinones as possible antiherpes viral agents. Ind Drugs 2006;43:497–502.
   Google Scholar
• Michel J, Cedric L, Alexandra V, Besson T. Synthesis of novel -3H-Qinazoline-4-ones containing pyrazolinone, pyrazole and pyridinone moieties. Eur J Med Chem 2008;43:1469–77.
   PubMed Web of Science ®Google Scholar
• Kalil A, Hamide S, El-Sabbagh HI. Synthesis of some novel oxadiazole and Quinazoline 4-one analogues for their biological activity. Arch Pharm Chem 2003;2:95–103.
   Web of Science ®Google Scholar
• Abouzid K, Shouman S. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase. Bioorg Med Chem 2008;16:7543–51.
   PubMed Web of Science ®Google Scholar
• Siegel D, Gustafson DL, Dehn DL, et al. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 2004;65:1238–47.
   PubMed Web of Science ®Google Scholar
• Kwak MK, Wakabayashi N, Itoh K, et al. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J Biol Chem 2003;278:8135–45.
   PubMed Web of Science ®Google Scholar
• Nguyen T, Sherratt PJ, Pickett CB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 2003;43:233–60.
   PubMed Web of Science ®Google Scholar
• Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 2004;10:549–57.
   PubMed Web of Science ®Google Scholar
• Siegel D, Bolton EM, Burr JA, et al. The reduction of alpha tocopherolquinone by human NAD(P)H:quinone oxidoreductase: the role of alpha-tocopherolhydroquinone as a cellular antioxidant. Mol Pharmacol 1997;52:300–5.
   PubMed Web of Science ®Google Scholar
• Begleiter A, Fourie J. Induction of NQO1 in cancer cells. Methods Enzymol 2004;382:320–51.
   PubMed Web of Science ®Google Scholar
• Dhakshinamoorthy S, Jaiswal AK. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene 2001;20:3906–17.
   PubMed Web of Science ®Google Scholar
• Nioi P, Hayes JD. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat Res 2004;555:149–71.
   PubMed Web of Science ®Google Scholar
• Jaiswal AK. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 2004;36:1199–207.
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Talalay P, Sharkey J, et al. An exceptionally potent inducer of cytoprotective enzymes: elucidation of the structural features that determine inducer potency and reactivity with Keap1. J Biol Chem 2010;285:33747–55.
   PubMed Web of Science ®Google Scholar
• Honda T, Yoshizawa H, Sundararajan C, et al. Tricyclic compounds containing nonenolizable cyano enones. A novel class of highly potent anti-inflammatory and cytoprotective agents. J Med Chem 2011;54:1762–78.
   PubMed Web of Science ®Google Scholar
• Zheng S, Santosh Laxmi YR, David E, et al. Synthesis, chemical reactivity as Michael acceptors, and biological potency of mono-cyclic cyanoenones, novel and highly potent anti-inflammatory and cytoprotective agents. J Med Chem 2012;55:4837–46.
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Kostov RV. Glucosinolates and isothiocyanates in health and disease. Trends Mol Med 2012;18:337–47.
   PubMed Web of Science ®Google Scholar
• AlSaid MS, Ghorab MM, Higgins M, Dinkova-Kostova AT. NAD(P)H:quinone oxidoreductase 1 inducer activity of some enaminone derivatives. Biomed Res 2015;26:7–12.
   Web of Science ®Google Scholar
• Ghorab MM, Higgins M, Alsaid MS, et al. Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel cyanoenone and enone benzenesulfonamides. J Enzyme Inhib Med Chem 2014;29:840–5.
   PubMed Web of Science ®Google Scholar
• Ghorab MM, Ragab FA, Heiba HI, et al. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives. Eur J Med Chem 2015;92:682–92.
   PubMed Web of Science ®Google Scholar
• Ghorab MM, Alsaid MS, Ceruso M, et al. Carbonic anhydrase inhibitors: synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties. Bioorg Med Chem 2014;14:3684–95.
   Web of Science ®Google Scholar
• Ghorab MM, Ceruso M, Alsaid MS, et al. Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: synthesis, cytotoxic activity and molecular modeling. Eur J Med Chem 2014;87:186–96.
   PubMed Web of Science ®Google Scholar
• Fahey JW, Dinkova-Kostova AT, Stephenson KK, Talalay P. The “Prochaska” microtiter plate bioassay for inducers of NQO1. Methods Enzymol 2004;382:243–58.
   PubMed Web of Science ®Google Scholar